Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC2
|
ENSG00000169635.5 | HIC ZBTB transcriptional repressor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC2 | hg19_v2_chr22_+_21771656_21771693 | 0.32 | 8.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51487282 | 5.54 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr15_+_90728145 | 4.13 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr4_+_4388805 | 3.64 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr1_+_32042131 | 3.25 |
ENST00000271064.7
ENST00000537531.1 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr1_+_17531614 | 3.15 |
ENST00000375471.4
|
PADI1
|
peptidyl arginine deiminase, type I |
chr9_+_33750515 | 3.09 |
ENST00000361005.5
|
PRSS3
|
protease, serine, 3 |
chr12_-_52845910 | 3.07 |
ENST00000252252.3
|
KRT6B
|
keratin 6B |
chr1_+_32042105 | 3.03 |
ENST00000457433.2
ENST00000441210.2 |
TINAGL1
|
tubulointerstitial nephritis antigen-like 1 |
chr22_-_20367797 | 2.87 |
ENST00000424787.2
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
chr19_-_51487071 | 2.82 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr1_+_152881014 | 2.81 |
ENST00000368764.3
ENST00000392667.2 |
IVL
|
involucrin |
chr8_+_124194875 | 2.65 |
ENST00000522648.1
ENST00000276699.6 |
FAM83A
|
family with sequence similarity 83, member A |
chr16_-_30122717 | 2.52 |
ENST00000566613.1
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chr4_-_175443788 | 2.50 |
ENST00000541923.1
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD) |
chr5_+_96212185 | 2.49 |
ENST00000379904.4
|
ERAP2
|
endoplasmic reticulum aminopeptidase 2 |
chr17_-_26903900 | 2.49 |
ENST00000395319.3
ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC
|
aldolase C, fructose-bisphosphate |
chr5_-_139726181 | 2.49 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr6_+_151646800 | 2.48 |
ENST00000354675.6
|
AKAP12
|
A kinase (PRKA) anchor protein 12 |
chr10_+_102106829 | 2.46 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
chr17_-_39928106 | 2.41 |
ENST00000540235.1
|
JUP
|
junction plakoglobin |
chr1_-_50489547 | 2.41 |
ENST00000371836.1
ENST00000371839.1 ENST00000371838.1 |
AGBL4
|
ATP/GTP binding protein-like 4 |
chr22_+_30792980 | 2.41 |
ENST00000403484.1
ENST00000405717.3 ENST00000402592.3 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
chr10_-_43762329 | 2.37 |
ENST00000395810.1
|
RASGEF1A
|
RasGEF domain family, member 1A |
chr14_-_75422280 | 2.37 |
ENST00000238607.6
ENST00000553716.1 |
PGF
|
placental growth factor |
chr1_+_150522222 | 2.34 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
chr22_+_30792846 | 2.32 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
chr20_+_30102231 | 2.31 |
ENST00000335574.5
ENST00000340852.5 ENST00000398174.3 ENST00000376127.3 ENST00000344042.5 |
HM13
|
histocompatibility (minor) 13 |
chr10_-_5541525 | 2.29 |
ENST00000380332.3
|
CALML5
|
calmodulin-like 5 |
chr1_-_205419053 | 2.28 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
chr1_-_9189229 | 2.25 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr14_-_64194745 | 2.25 |
ENST00000247225.6
|
SGPP1
|
sphingosine-1-phosphate phosphatase 1 |
chr17_+_73717407 | 2.24 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
chr17_-_8059638 | 2.23 |
ENST00000584202.1
ENST00000354903.5 ENST00000577253.1 |
PER1
|
period circadian clock 1 |
chr17_+_73717551 | 2.23 |
ENST00000450894.3
|
ITGB4
|
integrin, beta 4 |
chr2_-_224903995 | 2.20 |
ENST00000409304.1
ENST00000454956.1 ENST00000258405.4 |
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 |
chrX_-_131623874 | 2.17 |
ENST00000436215.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr10_+_5566916 | 2.13 |
ENST00000315238.1
|
CALML3
|
calmodulin-like 3 |
chr9_+_131102925 | 2.08 |
ENST00000372870.1
ENST00000300456.4 |
SLC27A4
|
solute carrier family 27 (fatty acid transporter), member 4 |
chr9_+_33750667 | 2.04 |
ENST00000457896.1
ENST00000342836.4 ENST00000429677.3 |
PRSS3
|
protease, serine, 3 |
chr10_+_124221036 | 2.04 |
ENST00000368984.3
|
HTRA1
|
HtrA serine peptidase 1 |
chr7_+_134212312 | 2.04 |
ENST00000359579.4
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase) |
chr1_+_20915409 | 2.02 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
chr4_+_8201091 | 2.01 |
ENST00000382521.3
ENST00000245105.3 ENST00000457650.2 ENST00000539824.1 |
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr1_+_10270863 | 2.00 |
ENST00000377093.4
ENST00000263934.6 |
KIF1B
|
kinesin family member 1B |
chr22_+_38071615 | 1.99 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr17_+_4736627 | 1.98 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
chr1_+_153388993 | 1.98 |
ENST00000368729.4
|
S100A7A
|
S100 calcium binding protein A7A |
chr2_-_235405168 | 1.96 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr12_+_41086297 | 1.95 |
ENST00000551295.2
|
CNTN1
|
contactin 1 |
chr11_+_118826999 | 1.94 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
chr20_-_43280325 | 1.92 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
chr10_+_5454505 | 1.91 |
ENST00000355029.4
|
NET1
|
neuroepithelial cell transforming 1 |
chr7_-_27135591 | 1.90 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
chrX_-_153599578 | 1.90 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr20_-_54967187 | 1.90 |
ENST00000422322.1
ENST00000371356.2 ENST00000451915.1 ENST00000347343.2 ENST00000395911.1 ENST00000395907.1 ENST00000441357.1 ENST00000456249.1 ENST00000420474.1 ENST00000395909.4 ENST00000395914.1 ENST00000312783.6 ENST00000395915.3 ENST00000395913.3 |
AURKA
|
aurora kinase A |
chr21_-_47604318 | 1.89 |
ENST00000291672.5
ENST00000330205.6 |
SPATC1L
|
spermatogenesis and centriole associated 1-like |
chr10_-_33625154 | 1.89 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
chr2_+_113875466 | 1.86 |
ENST00000361779.3
ENST00000259206.5 ENST00000354115.2 |
IL1RN
|
interleukin 1 receptor antagonist |
chr2_-_1748214 | 1.85 |
ENST00000433670.1
ENST00000425171.1 ENST00000252804.4 |
PXDN
|
peroxidasin homolog (Drosophila) |
chr16_-_87903079 | 1.85 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
chr3_-_48594248 | 1.83 |
ENST00000545984.1
ENST00000232375.3 ENST00000416568.1 ENST00000383734.2 ENST00000541519.1 ENST00000412035.1 |
PFKFB4
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
chr17_+_1959369 | 1.83 |
ENST00000576444.1
ENST00000322941.3 |
HIC1
|
hypermethylated in cancer 1 |
chr1_-_231175964 | 1.82 |
ENST00000366654.4
|
FAM89A
|
family with sequence similarity 89, member A |
chr5_-_39270725 | 1.75 |
ENST00000512138.1
ENST00000512982.1 ENST00000540520.1 |
FYB
|
FYN binding protein |
chr17_+_7942335 | 1.74 |
ENST00000380183.4
ENST00000572022.1 ENST00000380173.2 |
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
chr1_+_152975488 | 1.73 |
ENST00000542696.1
|
SPRR3
|
small proline-rich protein 3 |
chr6_-_34524093 | 1.72 |
ENST00000544425.1
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr2_-_31361543 | 1.71 |
ENST00000349752.5
|
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
chr8_-_101661887 | 1.70 |
ENST00000311812.2
|
SNX31
|
sorting nexin 31 |
chr11_-_2170786 | 1.69 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr12_+_53491220 | 1.69 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr22_+_33197683 | 1.68 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr3_-_48632593 | 1.67 |
ENST00000454817.1
ENST00000328333.8 |
COL7A1
|
collagen, type VII, alpha 1 |
chr16_+_88704978 | 1.67 |
ENST00000244241.4
|
IL17C
|
interleukin 17C |
chr15_-_74659978 | 1.67 |
ENST00000541301.1
ENST00000416978.1 ENST00000268053.6 |
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1 |
chr18_+_21452964 | 1.66 |
ENST00000587184.1
|
LAMA3
|
laminin, alpha 3 |
chr8_+_124194752 | 1.66 |
ENST00000318462.6
|
FAM83A
|
family with sequence similarity 83, member A |
chr6_+_43739697 | 1.66 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
chr11_-_111783595 | 1.65 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr9_-_139891165 | 1.65 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
chr2_-_31360887 | 1.65 |
ENST00000420311.2
ENST00000356174.3 ENST00000324589.5 |
GALNT14
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
chr7_+_116165038 | 1.64 |
ENST00000393470.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr17_+_37821593 | 1.64 |
ENST00000578283.1
|
TCAP
|
titin-cap |
chr11_-_66675371 | 1.62 |
ENST00000393955.2
|
PC
|
pyruvate carboxylase |
chr11_-_2193025 | 1.62 |
ENST00000333684.5
ENST00000381178.1 ENST00000381175.1 ENST00000352909.3 |
TH
|
tyrosine hydroxylase |
chrX_-_48328631 | 1.57 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
chr3_-_50340996 | 1.57 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr5_-_39203093 | 1.57 |
ENST00000515010.1
|
FYB
|
FYN binding protein |
chr11_-_62323702 | 1.56 |
ENST00000530285.1
|
AHNAK
|
AHNAK nucleoprotein |
chr4_+_75230853 | 1.55 |
ENST00000244869.2
|
EREG
|
epiregulin |
chr11_-_62313090 | 1.54 |
ENST00000528508.1
ENST00000533365.1 |
AHNAK
|
AHNAK nucleoprotein |
chr2_-_47142884 | 1.53 |
ENST00000409105.1
ENST00000409973.1 ENST00000409913.1 ENST00000319466.4 |
MCFD2
|
multiple coagulation factor deficiency 2 |
chr11_+_129245796 | 1.52 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
chr6_-_34524049 | 1.52 |
ENST00000374037.3
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
chr19_-_51017881 | 1.51 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr17_+_79990058 | 1.50 |
ENST00000584341.1
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
chr14_-_35183755 | 1.50 |
ENST00000555765.1
|
CFL2
|
cofilin 2 (muscle) |
chr1_-_153363452 | 1.47 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr17_+_73717516 | 1.47 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
chrX_-_38080077 | 1.45 |
ENST00000378533.3
ENST00000544439.1 ENST00000432886.2 ENST00000538295.1 |
SRPX
|
sushi-repeat containing protein, X-linked |
chr11_-_2162468 | 1.45 |
ENST00000434045.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chrX_-_48328551 | 1.45 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
chr8_-_125740514 | 1.42 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
chr1_+_26606608 | 1.42 |
ENST00000319041.6
|
SH3BGRL3
|
SH3 domain binding glutamic acid-rich protein like 3 |
chr17_+_39975455 | 1.42 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr16_-_55867146 | 1.41 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
chr17_+_40704938 | 1.41 |
ENST00000225929.5
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1 |
chr1_-_47655686 | 1.41 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr5_+_167181917 | 1.39 |
ENST00000519204.1
|
TENM2
|
teneurin transmembrane protein 2 |
chr3_+_10206545 | 1.38 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr18_-_31802056 | 1.38 |
ENST00000538587.1
|
NOL4
|
nucleolar protein 4 |
chr19_+_41725088 | 1.37 |
ENST00000301178.4
|
AXL
|
AXL receptor tyrosine kinase |
chr6_+_74405804 | 1.36 |
ENST00000287097.5
|
CD109
|
CD109 molecule |
chrX_-_71351678 | 1.36 |
ENST00000609883.1
ENST00000545866.1 |
RGAG4
|
retrotransposon gag domain containing 4 |
chr4_-_8073705 | 1.35 |
ENST00000514025.1
|
ABLIM2
|
actin binding LIM protein family, member 2 |
chr9_+_132099158 | 1.35 |
ENST00000444125.1
|
RP11-65J3.1
|
RP11-65J3.1 |
chrX_-_131623982 | 1.35 |
ENST00000370844.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr6_-_30712313 | 1.34 |
ENST00000376377.2
ENST00000259874.5 |
IER3
|
immediate early response 3 |
chr19_-_51522955 | 1.34 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr8_-_41522719 | 1.34 |
ENST00000335651.6
|
ANK1
|
ankyrin 1, erythrocytic |
chr3_-_52567792 | 1.33 |
ENST00000307092.4
ENST00000422318.2 ENST00000459839.1 |
NT5DC2
|
5'-nucleotidase domain containing 2 |
chr11_-_66103932 | 1.33 |
ENST00000311320.4
|
RIN1
|
Ras and Rab interactor 1 |
chr8_+_10530133 | 1.32 |
ENST00000304519.5
|
C8orf74
|
chromosome 8 open reading frame 74 |
chr22_-_37640277 | 1.32 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr18_+_21269404 | 1.30 |
ENST00000313654.9
|
LAMA3
|
laminin, alpha 3 |
chr2_+_95940186 | 1.30 |
ENST00000403131.2
ENST00000317668.4 ENST00000317620.9 |
PROM2
|
prominin 2 |
chr22_-_20368028 | 1.29 |
ENST00000404912.1
|
GGTLC3
|
gamma-glutamyltransferase light chain 3 |
chr12_-_95009837 | 1.29 |
ENST00000551457.1
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr22_+_42949925 | 1.27 |
ENST00000327678.5
ENST00000340239.4 ENST00000407614.4 ENST00000335879.5 |
SERHL2
|
serine hydrolase-like 2 |
chr8_-_144655141 | 1.26 |
ENST00000398882.3
|
MROH6
|
maestro heat-like repeat family member 6 |
chr22_+_25003626 | 1.26 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chr1_-_6545502 | 1.25 |
ENST00000535355.1
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr3_+_52350335 | 1.25 |
ENST00000420323.2
|
DNAH1
|
dynein, axonemal, heavy chain 1 |
chr6_+_160769300 | 1.25 |
ENST00000275300.2
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
chr1_+_24646002 | 1.24 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr10_-_17659234 | 1.24 |
ENST00000466335.1
|
PTPLA
|
protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A |
chr5_+_135385202 | 1.24 |
ENST00000514554.1
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa |
chr6_-_39290316 | 1.24 |
ENST00000425054.2
ENST00000373227.4 ENST00000373229.5 ENST00000437525.2 |
KCNK16
|
potassium channel, subfamily K, member 16 |
chr3_+_136537911 | 1.23 |
ENST00000393079.3
|
SLC35G2
|
solute carrier family 35, member G2 |
chr1_+_156830607 | 1.22 |
ENST00000368196.3
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1 |
chr6_-_112080256 | 1.21 |
ENST00000462856.2
ENST00000229471.4 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr15_-_74504597 | 1.21 |
ENST00000416286.3
|
STRA6
|
stimulated by retinoic acid 6 |
chr14_+_85996471 | 1.21 |
ENST00000330753.4
|
FLRT2
|
fibronectin leucine rich transmembrane protein 2 |
chr3_+_100354442 | 1.20 |
ENST00000475887.1
|
GPR128
|
G protein-coupled receptor 128 |
chr1_+_10057274 | 1.20 |
ENST00000294435.7
|
RBP7
|
retinol binding protein 7, cellular |
chrX_+_68048803 | 1.20 |
ENST00000204961.4
|
EFNB1
|
ephrin-B1 |
chr17_-_76870126 | 1.20 |
ENST00000586057.1
|
TIMP2
|
TIMP metallopeptidase inhibitor 2 |
chr22_-_26961328 | 1.20 |
ENST00000398110.2
|
TPST2
|
tyrosylprotein sulfotransferase 2 |
chr19_-_39264072 | 1.19 |
ENST00000599035.1
ENST00000378626.4 |
LGALS7
|
lectin, galactoside-binding, soluble, 7 |
chr2_-_70780770 | 1.18 |
ENST00000444975.1
ENST00000445399.1 ENST00000418333.2 |
TGFA
|
transforming growth factor, alpha |
chr15_-_74504560 | 1.18 |
ENST00000449139.2
|
STRA6
|
stimulated by retinoic acid 6 |
chr1_-_152552980 | 1.18 |
ENST00000368787.3
|
LCE3D
|
late cornified envelope 3D |
chr3_-_12800751 | 1.17 |
ENST00000435218.2
ENST00000435575.1 |
TMEM40
|
transmembrane protein 40 |
chr17_-_34122596 | 1.17 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chr1_-_6557441 | 1.17 |
ENST00000400915.3
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
chr7_+_143013198 | 1.17 |
ENST00000343257.2
|
CLCN1
|
chloride channel, voltage-sensitive 1 |
chr18_-_31628558 | 1.16 |
ENST00000535384.1
|
NOL4
|
nucleolar protein 4 |
chr17_+_6544078 | 1.16 |
ENST00000250101.5
|
TXNDC17
|
thioredoxin domain containing 17 |
chr22_-_30685596 | 1.16 |
ENST00000404953.3
ENST00000407689.3 |
GATSL3
|
GATS protein-like 3 |
chr17_+_7210852 | 1.16 |
ENST00000576930.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr11_-_66103867 | 1.15 |
ENST00000424433.2
|
RIN1
|
Ras and Rab interactor 1 |
chr13_-_25745857 | 1.14 |
ENST00000381853.3
|
AMER2
|
APC membrane recruitment protein 2 |
chr8_-_143696833 | 1.14 |
ENST00000356613.2
|
ARC
|
activity-regulated cytoskeleton-associated protein |
chr2_+_37571717 | 1.13 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
chr14_-_51411194 | 1.13 |
ENST00000544180.2
|
PYGL
|
phosphorylase, glycogen, liver |
chr1_-_156675368 | 1.13 |
ENST00000368222.3
|
CRABP2
|
cellular retinoic acid binding protein 2 |
chr10_-_76995675 | 1.12 |
ENST00000469299.1
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
chr9_-_131486367 | 1.12 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
chr11_-_2162162 | 1.11 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr2_+_64681103 | 1.11 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
chr15_-_101084446 | 1.11 |
ENST00000538112.2
ENST00000559639.1 ENST00000558884.2 |
CERS3
|
ceramide synthase 3 |
chr14_-_35183886 | 1.10 |
ENST00000298159.6
|
CFL2
|
cofilin 2 (muscle) |
chr7_+_147830776 | 1.10 |
ENST00000538075.1
|
CNTNAP2
|
contactin associated protein-like 2 |
chr2_-_85636928 | 1.10 |
ENST00000449030.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr2_-_96781984 | 1.09 |
ENST00000409345.3
|
ADRA2B
|
adrenoceptor alpha 2B |
chr8_-_125740730 | 1.09 |
ENST00000354184.4
|
MTSS1
|
metastasis suppressor 1 |
chr2_+_37571845 | 1.09 |
ENST00000537448.1
|
QPCT
|
glutaminyl-peptide cyclotransferase |
chr13_+_52158610 | 1.09 |
ENST00000298125.5
|
WDFY2
|
WD repeat and FYVE domain containing 2 |
chr12_-_85306594 | 1.09 |
ENST00000266682.5
|
SLC6A15
|
solute carrier family 6 (neutral amino acid transporter), member 15 |
chr16_-_55866997 | 1.09 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
chr19_-_51523412 | 1.08 |
ENST00000391805.1
ENST00000599077.1 |
KLK10
|
kallikrein-related peptidase 10 |
chr22_-_20255212 | 1.08 |
ENST00000416372.1
|
RTN4R
|
reticulon 4 receptor |
chr18_-_31803169 | 1.08 |
ENST00000590712.1
|
NOL4
|
nucleolar protein 4 |
chr17_-_7297519 | 1.07 |
ENST00000576362.1
ENST00000571078.1 |
TMEM256-PLSCR3
|
TMEM256-PLSCR3 readthrough (NMD candidate) |
chr17_-_34502410 | 1.07 |
ENST00000398801.3
|
TBC1D3B
|
TBC1 domain family, member 3B |
chr14_-_94421923 | 1.07 |
ENST00000555507.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
chr12_+_6493319 | 1.07 |
ENST00000536876.1
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3) |
chr20_-_1306351 | 1.07 |
ENST00000381812.1
|
SDCBP2
|
syndecan binding protein (syntenin) 2 |
chr1_+_155178518 | 1.07 |
ENST00000316721.4
|
MTX1
|
metaxin 1 |
chr12_+_53443963 | 1.07 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr18_+_21269556 | 1.07 |
ENST00000399516.3
|
LAMA3
|
laminin, alpha 3 |
chr15_-_101084547 | 1.07 |
ENST00000394113.1
|
CERS3
|
ceramide synthase 3 |
chr2_+_85811525 | 1.07 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
chr2_+_69001913 | 1.06 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr10_-_76995769 | 1.06 |
ENST00000372538.3
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
chr1_+_155006300 | 1.05 |
ENST00000295542.1
ENST00000392480.1 ENST00000423025.2 ENST00000368419.2 |
DCST1
|
DC-STAMP domain containing 1 |
chr6_+_47666275 | 1.05 |
ENST00000327753.3
ENST00000283303.2 |
GPR115
|
G protein-coupled receptor 115 |
chr1_+_24645865 | 1.05 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr20_-_56284816 | 1.04 |
ENST00000395819.3
ENST00000341744.3 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr3_-_127541194 | 1.04 |
ENST00000453507.2
|
MGLL
|
monoglyceride lipase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 8.4 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
1.0 | 3.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
1.0 | 2.9 | GO:0097187 | dentinogenesis(GO:0097187) |
0.9 | 2.7 | GO:0018199 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) peptidyl-glutamine modification(GO:0018199) |
0.9 | 2.6 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.8 | 2.4 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.7 | 2.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.7 | 2.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.6 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.6 | 1.9 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.6 | 1.9 | GO:1900195 | spindle assembly involved in female meiosis I(GO:0007057) positive regulation of oocyte maturation(GO:1900195) |
0.6 | 3.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.6 | 1.8 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.6 | 2.4 | GO:1904647 | response to rotenone(GO:1904647) |
0.6 | 1.8 | GO:0032499 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
0.6 | 5.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 2.3 | GO:2001287 | negative regulation of caveolin-mediated endocytosis(GO:2001287) |
0.6 | 2.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.6 | 2.3 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.6 | 8.5 | GO:0035878 | nail development(GO:0035878) |
0.6 | 2.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.6 | 6.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.5 | 1.6 | GO:0072186 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.5 | 2.7 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.5 | 1.6 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.5 | 1.6 | GO:0044209 | AMP salvage(GO:0044209) |
0.5 | 1.5 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.5 | 2.0 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.5 | 1.5 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.5 | 2.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.5 | 1.5 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.5 | 1.4 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.5 | 2.4 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.5 | 2.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.5 | 1.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.5 | 0.9 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.5 | 2.3 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.5 | 1.8 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.4 | 2.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.4 | 3.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 2.5 | GO:0030035 | microspike assembly(GO:0030035) |
0.4 | 0.8 | GO:0042310 | vasoconstriction(GO:0042310) |
0.4 | 1.7 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 2.5 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.4 | 1.2 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.4 | 2.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.4 | 0.8 | GO:0009409 | response to cold(GO:0009409) |
0.4 | 2.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.4 | 0.8 | GO:0010165 | response to X-ray(GO:0010165) |
0.4 | 0.4 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.4 | 1.9 | GO:0038189 | vestibulocochlear nerve structural organization(GO:0021649) neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) positive regulation of retinal ganglion cell axon guidance(GO:1902336) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.4 | 0.4 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.4 | 1.4 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.4 | 1.4 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 0.3 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.3 | 1.0 | GO:0035624 | receptor transactivation(GO:0035624) |
0.3 | 2.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.3 | 6.0 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.3 | 1.7 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 1.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
0.3 | 1.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.3 | 1.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.3 | 1.9 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.3 | 0.6 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.3 | 1.9 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.3 | 0.9 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.3 | 1.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 3.6 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.3 | 1.5 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.3 | 1.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 6.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.9 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.3 | 0.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 2.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 2.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.3 | 0.9 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 2.2 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.3 | 1.7 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.9 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.3 | 1.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.3 | 0.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.8 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 | 2.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.3 | 0.8 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 3.5 | GO:0015816 | glycine transport(GO:0015816) |
0.2 | 0.7 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 1.0 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 0.5 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.2 | 1.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
0.2 | 1.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.2 | 1.0 | GO:0031052 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.2 | 0.7 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.2 | 1.7 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.2 | 1.0 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 0.2 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.2 | 1.2 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 3.3 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 1.6 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.2 | 2.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 0.7 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.2 | 1.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.9 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.2 | 2.0 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 1.3 | GO:0038096 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.2 | 0.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.2 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.2 | 0.4 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.2 | 1.0 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.2 | 0.6 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.2 | 1.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.2 | 4.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.8 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 0.2 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 1.6 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.2 | 2.8 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 0.8 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.2 | 0.6 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 0.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 1.4 | GO:2000669 | positive regulation of pinocytosis(GO:0048549) negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.2 | 0.6 | GO:1904640 | response to methionine(GO:1904640) |
0.2 | 0.8 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.2 | 0.6 | GO:0014062 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
0.2 | 0.4 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 5.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.4 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.2 | 2.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.2 | 0.8 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.2 | 0.6 | GO:0060364 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) frontal suture morphogenesis(GO:0060364) modulation by virus of host immune response(GO:0075528) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.2 | 2.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.2 | 0.9 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.2 | 0.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.2 | 1.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 1.1 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
0.2 | 0.7 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.2 | 3.1 | GO:0090179 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.2 | 2.5 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 1.4 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.2 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.7 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.2 | 1.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 0.8 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.0 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.7 | GO:2000230 | pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.2 | 1.0 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 2.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 1.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.2 | 1.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.2 | 0.5 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.2 | 2.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 1.7 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 3.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 0.5 | GO:0036484 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.2 | 0.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 0.9 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 3.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.3 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.1 | 0.1 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.2 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.6 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
0.1 | 1.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 1.1 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.8 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 1.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 2.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.7 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.4 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.5 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
0.1 | 0.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.3 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.1 | 2.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.1 | 1.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.5 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0060872 | semicircular canal development(GO:0060872) |
0.1 | 2.3 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.1 | 0.1 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.1 | 0.4 | GO:0048627 | myoblast development(GO:0048627) |
0.1 | 0.4 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.1 | 2.0 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.5 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 1.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 2.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 1.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 1.6 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.2 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.1 | 0.6 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 1.6 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 3.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.7 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.1 | 0.7 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.6 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.1 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.5 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.5 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.9 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.1 | 1.3 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.5 | GO:0007538 | primary sex determination(GO:0007538) |
0.1 | 3.5 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.7 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.1 | 0.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 4.4 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.1 | 1.9 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.8 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.2 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
0.1 | 0.5 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.3 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 5.4 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 1.6 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.9 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 1.1 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 0.3 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 0.9 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.1 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.9 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.1 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 1.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 1.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:0018011 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.2 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.1 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
0.1 | 0.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.1 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.3 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.1 | 0.3 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.5 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.1 | 1.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 1.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.4 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.1 | 0.3 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 3.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.6 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 1.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 0.4 | GO:0071469 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) cellular response to alkaline pH(GO:0071469) |
0.1 | 0.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.4 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.1 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.5 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.1 | 0.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 2.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.9 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 0.1 | GO:0097695 | establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.1 | 0.7 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.3 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.4 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 5.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 0.3 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.1 | 1.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.9 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.3 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.9 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.1 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 1.0 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.4 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 1.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.2 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 1.2 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.2 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
0.1 | 0.7 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 1.3 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 2.4 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.3 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 0.8 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 0.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.6 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 9.1 | GO:0070268 | cornification(GO:0070268) |
0.1 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 1.7 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.4 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.4 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.1 | 0.8 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.1 | 1.5 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 0.8 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.2 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.2 | GO:0045110 | neurofilament bundle assembly(GO:0033693) intermediate filament bundle assembly(GO:0045110) |
0.1 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 3.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 1.4 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.1 | 3.3 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.5 | GO:0021559 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) thorax and anterior abdomen determination(GO:0007356) trigeminal nerve development(GO:0021559) |
0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.8 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 0.2 | GO:0071301 | transcription factor catabolic process(GO:0036369) cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.1 | 0.8 | GO:0060346 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.8 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.9 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 1.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.2 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.2 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.2 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 3.6 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.1 | 0.2 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.1 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.6 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 1.2 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 1.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 | 0.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.1 | 1.9 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.4 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.1 | 0.9 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.4 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.4 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.9 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.1 | 0.5 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.9 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.1 | 0.2 | GO:0019413 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.1 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.5 | GO:0042325 | regulation of phosphorylation(GO:0042325) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.9 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
0.1 | 1.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.0 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 0.4 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.2 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.0 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 3.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.0 | 0.7 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.3 | GO:0045939 | negative regulation of steroid metabolic process(GO:0045939) |
0.0 | 1.3 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.0 | 0.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.0 | 0.3 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.0 | 1.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.7 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.2 | GO:0060348 | bone development(GO:0060348) |
0.0 | 0.2 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.4 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.2 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.0 | 0.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.3 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.0 | 0.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.5 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.3 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.2 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
0.0 | 1.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) disaccharide biosynthetic process(GO:0046351) |
0.0 | 0.4 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.0 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.0 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.0 | 0.8 | GO:0030325 | adrenal gland development(GO:0030325) |
0.0 | 0.5 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.3 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
0.0 | 0.2 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.4 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 1.1 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.1 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.0 | 2.9 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.0 | 0.0 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.0 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.0 | 0.2 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 2.1 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.4 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.1 | GO:0061326 | renal tubule development(GO:0061326) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.2 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) negative regulation of fibrinolysis(GO:0051918) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.3 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.1 | GO:0021564 | vagus nerve development(GO:0021564) |
0.0 | 0.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.7 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.8 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.2 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.0 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 1.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.0 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
0.0 | 0.1 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.2 | GO:0051705 | multi-organism behavior(GO:0051705) |
0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 1.3 | GO:0048512 | circadian behavior(GO:0048512) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.0 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.0 | 0.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.0 | 0.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.2 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.5 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.0 | 0.3 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.2 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.5 | GO:1904778 | protein localization to cell cortex(GO:0072697) regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.2 | GO:0097240 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.0 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.3 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.7 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.8 | GO:0019228 | neuronal action potential(GO:0019228) |
0.0 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.0 | 0.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.9 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:0048073 | regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
0.0 | 1.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.8 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 1.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.1 | GO:1901656 | glycoside transport(GO:1901656) |
0.0 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 0.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.3 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.0 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.7 | GO:0015695 | organic cation transport(GO:0015695) |
0.0 | 0.3 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) negative regulation of myoblast fusion(GO:1901740) regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.0 | 0.2 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.0 | 0.3 | GO:1990035 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.0 | 0.4 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.0 | GO:0032898 | neurotrophin production(GO:0032898) regulation of neurotrophin production(GO:0032899) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 1.0 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.0 | 0.7 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.2 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.4 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.1 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.1 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.0 | 0.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
0.0 | 0.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.2 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.0 | 0.1 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.1 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.0 | 0.0 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.0 | 0.4 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.3 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.3 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 0.2 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.7 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.2 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.2 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.0 | 0.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.0 | 0.2 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.1 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.2 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.2 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.1 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.0 | 0.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.0 | 1.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0034393 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.0 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.1 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.0 | 0.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.0 | 0.9 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.7 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 2.7 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.2 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.0 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.5 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.0 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.3 | GO:0009967 | positive regulation of signal transduction(GO:0009967) |
0.0 | 0.2 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.0 | 0.2 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.0 | 0.2 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.0 | 0.2 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.0 | 0.0 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.3 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.4 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.3 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.2 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.5 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.1 | GO:1904869 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
0.0 | 0.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0019827 | stem cell population maintenance(GO:0019827) |
0.0 | 0.2 | GO:0072413 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.0 | 0.0 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.0 | 0.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.1 | GO:2001243 | negative regulation of intrinsic apoptotic signaling pathway(GO:2001243) |
0.0 | 0.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.2 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 0.1 | GO:0051493 | regulation of cytoskeleton organization(GO:0051493) |
0.0 | 0.2 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.0 | 0.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.1 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.6 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 8.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.8 | 2.5 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.6 | 1.9 | GO:0031523 | Myb complex(GO:0031523) |
0.6 | 4.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.5 | 1.6 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 1.5 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.5 | 1.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 2.3 | GO:0044393 | microspike(GO:0044393) |
0.4 | 8.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 1.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 3.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.4 | 2.0 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.4 | 1.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.4 | 1.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.3 | 1.0 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.3 | 2.7 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 1.0 | GO:0097447 | dendritic tree(GO:0097447) |
0.3 | 1.0 | GO:0043259 | laminin-2 complex(GO:0005607) laminin-10 complex(GO:0043259) |
0.3 | 1.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.3 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 1.0 | GO:0045160 | myosin I complex(GO:0045160) |
0.2 | 1.7 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 1.4 | GO:0033643 | host cell part(GO:0033643) |
0.2 | 1.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 2.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 0.6 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.2 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 2.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.5 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.2 | 0.5 | GO:1990031 | pinceau fiber(GO:1990031) |
0.2 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 2.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.7 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.2 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.0 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.5 | GO:0035841 | new growing cell tip(GO:0035841) |
0.2 | 1.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.9 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 1.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 2.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.1 | 0.4 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.1 | 1.3 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 2.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.7 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.5 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.6 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 2.4 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 10.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 0.4 | GO:0016938 | kinesin I complex(GO:0016938) |
0.1 | 1.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.8 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 8.9 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 2.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.8 | GO:0032059 | bleb(GO:0032059) |
0.1 | 2.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 0.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 3.7 | GO:0043034 | costamere(GO:0043034) |
0.1 | 1.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 1.0 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 5.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.1 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.8 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 1.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.2 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 0.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 0.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 3.0 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 2.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.8 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.0 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 1.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.5 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.1 | 3.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 1.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.0 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 4.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.3 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.3 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.1 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 1.3 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 6.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.5 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.4 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 2.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 1.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 0.6 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 4.5 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.2 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 3.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.2 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 1.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.0 | 8.4 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.6 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.0 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 4.4 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.0 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.5 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 1.0 | GO:0031253 | cell projection membrane(GO:0031253) |
0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.0 | 0.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 5.5 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 3.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 2.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 1.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 1.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.1 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 0.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 1.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.1 | GO:0097444 | spine apparatus(GO:0097444) |
0.0 | 0.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.7 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 4.6 | GO:0031674 | I band(GO:0031674) |
0.0 | 0.2 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 2.0 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.1 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.0 | 5.1 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 2.8 | GO:0043197 | dendritic spine(GO:0043197) neuron spine(GO:0044309) |
0.0 | 2.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 2.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 3.0 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.2 | GO:0044449 | contractile fiber part(GO:0044449) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 1.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.6 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 2.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 2.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:0098855 | HCN channel complex(GO:0098855) |
0.0 | 0.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.0 | 0.2 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.0 | 0.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.0 | 0.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.0 | 0.3 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.0 | 1.0 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 2.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.2 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 1.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.2 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.4 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 1.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 3.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 2.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.4 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.0 | 1.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0032426 | stereocilium tip(GO:0032426) |
0.0 | 0.0 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 2.6 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.0 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 1.0 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.8 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.0 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.9 | 2.7 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.9 | 2.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.7 | 3.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.7 | 2.1 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.6 | 8.4 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 2.5 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.6 | 2.5 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.6 | 1.8 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.6 | 1.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.6 | 1.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.6 | 0.6 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.6 | 2.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 2.0 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.5 | 2.5 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.5 | 2.0 | GO:0030395 | lactose binding(GO:0030395) |
0.5 | 1.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 1.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.5 | 1.4 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.4 | 3.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.4 | 1.3 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.4 | 2.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.4 | 1.6 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.4 | 3.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.4 | 0.8 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 2.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 1.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.4 | 1.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.4 | 2.3 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.4 | 1.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.4 | 1.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.4 | 1.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.3 | 1.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.3 | 1.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 2.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 1.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 6.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 1.0 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.3 | 4.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 1.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.3 | 1.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 3.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.3 | 2.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 1.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 2.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 0.6 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 1.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 1.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 1.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.3 | 0.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 2.4 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.3 | 1.1 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.3 | 1.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 1.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 1.0 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.2 | 1.9 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 1.6 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 2.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.2 | 0.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.2 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.2 | 2.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 0.7 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
0.2 | 1.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.2 | 1.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 0.9 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 2.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.2 | 0.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 5.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.2 | 3.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 0.8 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.2 | 4.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.2 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 0.6 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.2 | 0.2 | GO:0010853 | calcium sensitive guanylate cyclase activator activity(GO:0008048) cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.8 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.2 | 0.6 | GO:0050072 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) m7G(5')pppN diphosphatase activity(GO:0050072) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.2 | 1.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.6 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.2 | 0.7 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.2 | 1.7 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.2 | 0.5 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 0.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.2 | 3.8 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.7 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.2 | 0.8 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.8 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.2 | 3.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.2 | 1.6 | GO:0004075 | biotin carboxylase activity(GO:0004075) biotin binding(GO:0009374) |
0.2 | 1.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 6.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 1.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.2 | 2.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 3.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.6 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.1 | 0.9 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.1 | 0.6 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.1 | 0.4 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.1 | 0.6 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.1 | 1.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.0 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 2.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 2.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 2.1 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.1 | 0.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 2.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.9 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.5 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 1.1 | GO:0008526 | phosphatidylcholine transporter activity(GO:0008525) phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.7 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 0.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 2.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 3.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.7 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.5 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 1.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 1.0 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.8 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.1 | 0.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.1 | 0.3 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.1 | 1.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.9 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 3.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.1 | 2.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 0.4 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 2.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 1.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 1.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.4 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.4 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.1 | 0.6 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.1 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.7 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.5 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.7 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 2.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.1 | 0.3 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.1 | 12.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.4 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 2.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.9 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.1 | 2.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 1.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 2.4 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.2 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
0.1 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 0.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.4 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.7 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 1.3 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 1.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 0.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 1.0 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.4 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.4 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.1 | 0.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 1.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 2.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 4.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.6 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.2 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 0.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.1 | 0.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.5 | GO:0048495 | Roundabout binding(GO:0048495) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 2.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 2.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.5 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.6 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 1.2 | GO:0005543 | phospholipid binding(GO:0005543) |
0.1 | 2.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.1 | 0.2 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
0.1 | 1.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.2 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 2.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 3.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 1.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 2.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 2.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 0.6 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.7 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 1.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 1.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 0.2 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 1.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 1.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.7 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.0 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.2 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.2 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 1.4 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 1.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 3.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.0 | 0.5 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.3 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 2.2 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.0 | 2.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 1.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 1.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 5.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.5 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.4 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.1 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.0 | 0.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.0 | 0.2 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 8.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 1.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.5 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.0 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.0 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.0 | 0.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.0 | 0.8 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.4 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 8.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 3.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.7 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.5 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.2 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.0 | 0.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.1 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.0 | 0.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.8 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 1.3 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.5 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.1 | GO:0035473 | lipase binding(GO:0035473) |
0.0 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.0 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 1.3 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 1.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) SAM domain binding(GO:0032093) |
0.0 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.0 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 1.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 1.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 1.6 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.9 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
0.0 | 1.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.5 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.0 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 1.9 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 0.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.6 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.0 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.1 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 1.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 1.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 7.8 | GO:0005198 | structural molecule activity(GO:0005198) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.1 | GO:0031730 | CCR1 chemokine receptor binding(GO:0031726) CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.0 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.3 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.0 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.1 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 14.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.3 | 6.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 4.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 2.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 3.8 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.0 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 5.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 3.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 7.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 10.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 2.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 2.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 5.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 5.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 4.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 3.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 2.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 1.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 1.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 1.7 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 1.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 3.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 15.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 1.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 3.2 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.4 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 1.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 9.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.8 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 1.0 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.9 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 1.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 1.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 1.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.0 | 0.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.2 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 0.0 | PID ALK2 PATHWAY | ALK2 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.9 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 7.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 4.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 3.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 2.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.2 | 2.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 4.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 3.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 1.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 3.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 5.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 6.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 15.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 2.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 4.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 2.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 0.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 5.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 2.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 3.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 6.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 1.8 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 1.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 1.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.9 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 3.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.8 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 2.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 2.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 1.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 3.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 2.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 2.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 2.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 1.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.4 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.1 | 1.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.7 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 2.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 1.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.2 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 3.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 2.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 1.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 2.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 2.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 1.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.0 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME HIV LIFE CYCLE | Genes involved in HIV Life Cycle |
0.0 | 0.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.1 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 2.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.7 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.0 | 0.5 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.0 | 1.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 2.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.4 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 3.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.0 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 0.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 1.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.6 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.3 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.6 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |